PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Ukoniq (Generic Umbralisib)

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.

Why is this medication prescribed?

Ukoniq (umbralisib) is a prescription medication used in the treatment of certain types of cancer. Specifically, it is indicated for the treatment of:

  • Relapsed or refractory marginal zone lymphoma (MZL): Ukoniq is approved for adult patients with MZL who have received at least one prior anti-CD20-based regimen.
  • Relapsed or refractory follicular lymphoma (FL): It is also indicated for adult patients with FL who have received at least three prior lines of systemic therapy.

Ukoniq is a kinase inhibitor that works by interfering with certain signaling pathways involved in the growth and survival of cancer cells. It is important to note that prescribing medications, including Ukoniq, depends on the specific characteristics of the patient and the type and stage of cancer they are dealing with. Always consult with a qualified healthcare professional for the most up-to-date and personalized information regarding medications and their indications.

How should this medicine be used?

The dosing and administration of Ukoniq (umbralisib) should be based on the prescribing healthcare provider’s instructions and the specific details of the patient’s condition. The information provided here is a general guideline, and it is crucial to follow the prescribed regimen and consult with the healthcare team for personalized advice.

As of last update, the typical dosing for Ukoniq is as follows:

  • Dosage: The recommended dose is usually taken orally, and it may vary depending on the specific type of lymphoma being treated. The healthcare provider will determine the appropriate dosage for the individual patient.
  • Schedule: Ukoniq is often taken once daily.
  • Administration: The medication is typically taken with or without food. The tablets should be swallowed whole with water and should not be crushed, cut, or chewed.
  • Monitoring: Patients taking Ukoniq may undergo regular monitoring, including blood tests, to assess their response to the medication and monitor for potential side effects.

It’s important for patients to adhere to the prescribed dosage and schedule and to report any side effects or concerns to their healthcare provider promptly. Additionally, patients should inform their healthcare team about any other medications, supplements, or medical conditions they have, as these factors can influence the safety and effectiveness of Ukoniq.

Since medical guidelines and drug information can change, it’s crucial to consult with the prescribing healthcare provider or a healthcare professional for the most up-to-date and accurate information regarding the use of Ukoniq.

Other uses for this medicine

As of last update, Ukoniq is primarily indicated for the treatment of relapsed or refractory marginal zone lymphoma (MZL) and relapsed or refractory follicular lymphoma (FL). It is a kinase inhibitor that targets certain signaling pathways involved in the growth and survival of cancer cells.

What special precautions should I follow?

As for special precautions, it’s crucial to follow your healthcare provider’s advice and the prescribing information for Ukoniq. Here are some general precautions that may apply:

  • Liver Function: Ukoniq may affect liver function. Your healthcare provider may monitor your liver function through blood tests, and you should promptly report any signs of liver problems, such as jaundice (yellowing of the skin or eyes), dark urine, or persistent nausea.
  • Infections: Ukoniq may increase the risk of infections. Inform your healthcare provider if you experience signs of infection, such as fever, chills, or persistent cough.
  • Diarrhea: Diarrhea is a common side effect of Ukoniq. Your healthcare provider may provide guidance on managing diarrhea, and it’s important to stay hydrated. Severe or persistent diarrhea should be reported to your healthcare provider.
  • Interactions with Other Medications: Inform your healthcare provider about all medications, including prescription drugs, over-the-counter products, and dietary supplements, that you are taking. Ukoniq may interact with other medications, and adjustments may be needed.
  • Pregnancy and Breastfeeding: Ukoniq may harm an unborn baby. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your healthcare provider.
  • Allergic Reactions: Report any signs of allergic reactions, such as rash, itching, swelling, severe dizziness, or difficulty breathing, to your healthcare provider.

Always follow your healthcare provider’s instructions, attend scheduled appointments, and communicate any concerns or side effects promptly. This information is based on knowledge, and there may have been developments or updates.

What special dietary instructions should I follow?

There were no specific dietary restrictions associated with Ukoniq. However, it’s crucial to follow any dietary advice or restrictions provided by your healthcare provider. They may advise you based on your overall health and specific medical condition.

What should I do if I forget a dose?

If you forget to take a dose of Ukoniq, follow these general guidelines:

  • Missed Dose: Take the missed dose as soon as you remember on the same day.
  • Skip If Close to Next Dose: If it’s almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
  • Do Not Double Up: Do not take a double dose to make up for a missed one. Taking more than the prescribed amount can increase the risk of side effects.

What side effects can this medication cause?

Ukoniq (umbralisib) is a medication used to treat certain types of lymphomas, specifically relapsed or refractory marginal zone lymphoma (MZL) and follicular lymphoma (FL). Like all medications, Ukoniq can cause side effects. It’s important to note that individual responses to medications vary, and not everyone will experience the same side effects. Additionally, new information may have emerged since last update.

Common side effects associated with Ukoniq may include:

  • Diarrhea: Diarrhea is a common side effect and can range from mild to severe. It’s important to stay hydrated, and your healthcare provider may provide guidance on managing diarrhea.
  • Fatigue: Feeling tired or experiencing fatigue is a common side effect of Ukoniq.
  • Nausea: Some individuals may experience nausea while taking Ukoniq.
  • Cough: Coughing may occur as a side effect.
  • Respiratory Infections: There may be an increased risk of respiratory infections.
  • Elevated Liver Enzymes: Ukoniq may affect liver function, leading to elevated liver enzymes. Regular monitoring of liver function may be required.
  • Muscle and Joint Pain: Some individuals may experience muscle or joint pain.

It’s important to report any side effects to your healthcare provider, especially if they are persistent, severe, or if you have concerns about them. Additionally, there may be other, less common side effects that are not listed here.

In some cases, Ukoniq may cause serious side effects, and it’s crucial to seek immediate medical attention if you experience symptoms such as:

  • Signs of an allergic reaction (e.g., rash, itching, swelling, severe dizziness, difficulty breathing)
  • Persistent or severe diarrhea
  • Symptoms of liver problems (e.g., yellowing of the skin or eyes, dark urine)
  • Signs of infection (e.g., fever, chills, persistent cough)

This list is not exhaustive, and it’s essential to consult the prescribing information for Ukoniq and discuss any concerns with your healthcare provider. They can provide personalized information based on your medical history and overall health.

What should I know about storage and disposal of this medication?


  • Temperature: Store Ukoniq at room temperature, typically between 20°C to 25°C (68°F to 77°F). Avoid extreme temperatures and keep the medication away from direct sunlight.
  • Container: Keep Ukoniq in its original container or packaging to protect it from moisture and light.
  • Childproofing: Store Ukoniq in a location that is out of reach of children and pets.


  • Follow Local Guidelines: Dispose of Ukoniq according to local regulations and guidelines. Do not flush medications down the toilet unless instructed to do so.
  • Community Programs: Check if there are community drug take-back programs in your area that allow safe disposal of unused or expired medications.

In case of emergency/overdose

In case of emergency or overdose, seek immediate medical attention. Contact your local poison control center or emergency room. Symptoms of an overdose may include severe diarrhea, nausea, vomiting, or signs of liver problems.

What other information should I know?

  • Regular Monitoring: Attend regular follow-up appointments with your healthcare provider for monitoring of your response to Ukoniq and to manage any potential side effects.
  • Lab Tests: Your healthcare provider may perform regular blood tests, including liver function tests, to monitor for any abnormalities.
  • Informing Healthcare Providers: Keep your healthcare provider informed about all medications you are taking, including over-the-counter drugs and supplements.
  • Allergic Reactions: Be aware of signs of an allergic reaction, such as rash, itching, swelling, severe dizziness, or difficulty breathing. Seek immediate medical attention if these occur.
  • Pregnancy/Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits of Ukoniq with your healthcare provider.
  • Interactions: Be cautious about potential interactions with other medications. Inform your healthcare provider about all drugs and supplements you are taking.

Always consult with your healthcare provider or pharmacist for the most accurate and current information tailored to your specific situation. If there have been updates or changes since last update, they will provide the latest guidance.

Copyright © 2023